Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 472 |
|
Focus Thrombotic Microangiopathy NGS Panel Fulgent Genetics United States | 40 | 22 |
|
ATYPICAL HEMOLYTIC UREMIC SYNDROME Laboratorio de Genetica Clinica SL Spain | 7 | 7 |
|
Test for DGKE-Related Atypical Hemolytic Uremic Syndrome Secugen SL Spain | 8 | 1 |
|
Syndromes with immunodeficiency Panel CeGaT GmbH Germany | 33 | 38 |
|
Hemolytic uremic syndrome, atypical, susceptibility to, 4 Bioarray Spain | 1 | 1 |
|
Hemolytic Uremic Syndrome Panel CeGaT GmbH Germany | 6 | 12 |
|
CFB Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 1 | 1 |
|
Fulgent Genetics United States | 3 | 1 |
|
Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 1 | 1 |
|
Macular Degeneration NGS Panel Fulgent Genetics United States | 53 | 19 |
|
CFB-Related Atypical Hemolytic-Uremic Syndrome Secugen SL Spain | 1 | 1 |
|
Test for CFB-Related Atypical Hemolytic-Uremic Syndrome Genome Diagnostics Laboratory Hospital For Sick Children Canada | 1 | 1 |
|
Atypical hemolytic-uremic syndrome 4 Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders Germany | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.